sacituzumab govitecan
Commercial- Indications
- HR+/HER2- metastatic breast cancer, Triple-negative breast cancer
Company intelligence / Profile preview
International Breast Cancer Center
Barcelona, Catalonia, Spainibcc.clinic ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
IBCC is a leading hyper-specialized center in Spain for the treatment and research of breast cancer. It offers patient-centered care, access to innovative therapies through national and international clinical trials, and participates actively in translational research. The center is directed by Dr. Javier Cortés, an internationally recognized expert in breast oncology.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeMonoclonal antibody
- Industry
- Academic Hospital/University/Research
02
Drug pipeline
1 assetBeyond the preview
Go deeper on International Breast Cancer Center.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on International Breast Cancer Center.